The extracts of the leaves of three medicinal plants were found to be promising against seven types of cancers, according to researchers in Singapore.
Singapore researchers have discovered that cancer stem cells consume the amino acid methionine much faster than it can be generated, and this vulnerability could be exploited for cancer treatment.
Scientists in Japan have devised a nanoparticle carrier for siRNA that can access hard-to-reach tumors, such as those of the pancreas and the brain.
Under the terms of the collaboration with BeiGene, Ambrx will receive US$10 million to fund the initial discovery and research activities for novel biologic drug candidates.
ASLAN Pharmaceuticals will focus on clinical development of varlitinib while BioGenetics will obtain the necessary regulatory approvals for the use of the drug in South Korea.